CHAMGAP
APPROVEDReviewed and approved by the Chamgap Editorial Team (2026-08-01). The draft was written by AI, the existence of all 2 cited sources was verified at the original page, and the verdict passed blind grading and adversarial audit. Methodology v0.6.
Verdict No. 1924 · Search date 2026-08-01 · Methodology v0.6

Early endovenous ablation,
does it really help with Faster complete healing of venous leg ulcers?

30-Second Summary
A
Evidence Grade A · 80 · Safety caution
Adding early endovenous ablation to compression accelerated complete healing of venous leg ulcers
Postprocedural pain and venous thrombosis were reported. Vascular assessment, compression suitability, thrombosis risk, specialist technique, and follow-up are required.
What the
research shows
The grade is A. Complete healing is an actual closure of the skin defect, and blinded photographic review in EVRA found faster healing. After 450 participants were randomized, median healing was 56 days (95% CI 49 to 66) versus 82 days (69 to 92), HR 1.38 (1.13 to 1.68), P=0.001. Independent VUERT pointed the same way, and Cochrane pooled HR 1.41 (1.36 to 1.47), heterogeneity 0%, with high certainty, giving A with 80 points.
What the
ads claim
This does not show that vein procedures heal every chronic wound. It applies to venous ulcers with confirmed superficial reflux in people able to receive compression therapy.
*

Useful facts when choosing a product

  • EVRA delivered early endovenous treatment within two weeks of randomization.
  • The deferred group could receive ablation after healing or after six months if unhealed.
  • The trial allowed more than one thermal or nonthermal endovenous closure technique.
Gap Measurement · Verdict 1924 · A 80
What advertising claims
What independent, higher-quality research supports
△ GAP
01

What the research actually shows

The U.K. NIHR-funded EVRA trial randomized 450 participants, 224 to early and 226 to deferred ablation. Two ulcers had already healed before randomization and did not contribute to the survival analysis, so not all 450 contributed healing-time data. Median healing was 56 days (49 to 66) versus 82 days (69 to 92), HR 1.38 (1.13 to 1.68), P=0.001; healing at 24 weeks was 85.6% versus 76.3%. The independent Brazilian single-center VUERT trial randomized 56, 27 versus 29; median healing was 68 versus 77 days and healing velocity favored ablation, P=0.049, while healing rates themselves were not significant. Author lists did not overlap.

02

Why this is classified as A (80)

A large publicly funded trial accelerated blinded-confirmed actual healing, a nonoverlapping independent trial pointed the same way, and pooled certainty was high, giving A with 80 points.

Counterpoint. Complete healing is supported, but reduced one-year recurrence remains uncertain.

Rejudgment record. Cross-check applied — A large publicly funded trial accelerated blinded-photograph-confirmed complete healing, with nonoverlapping independent replication and high-certainty synthesis

Scoring profile behind this grade
EndpointHHard endpoint - actual events such as death
ReplicationR2Independently replicated across trials
IndependenceI2Decisive evidence is publicly or non-profit funded
Effect sizeE+Meets the clinically important threshold

The scoring table and the verdict agree (A).

Sub-claim grades by effect

This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.

Effect (sub-claim)GradeBasis
Shorter time to complete venous leg-ulcer healingAEVRA medians were 56 versus 82 days, and the pooled HR was 1.41.
Reduced ulcer recurrence at one yearDThe pooled RR was 0.29 with a very wide 95% CI of 0.03 to 2.48.

Cross-check — Codex and Claude

This verdict was drafted by Codex through literature review and source-existence checks, cross-checked through blind grading and adversarial audit, and settled by reapplying the methodology boundary rules. Cases with split grades were resolved through rejudgment.
03

Evidence Table

StudyDesignSampleFundingEndpointResultWeight
Study 120-center open randomized trial with blinded healing assessment2U.K. NIHR Health Technology Assessment ProgrammeTime to complete ulcer healingHR 1.38 (95% CI 1.13 to 1.68), P=0.001; median 56 days (49 to 66) versus 82 days (69 to 92); 24-week healing 85.6% versus 76.3%Pivotal large publicly funded evidence
Study 2Single-center open-label randomized trial29No commercial trial funding identified in the reportHealing at 6, 12, and 24 weeks and recurrence at 12 monthsHealing rates did not differ significantly; healing velocity favored ablation (P=0.049)Small independent evidence in the same direction
§

Receipt — 2 References

All 2 cited sources were verified for existence at the original page (as of 2026-08-01).

Gohel MS, Heatley F, Liu X, et al. A Randomized Trial of Early Endovenous Ablation in Venous Ulceration. N Engl J Med. 2018;378:2105-2114. PMID: 29688123. DOI: 10.1056/NEJMoa1801214.
checked
Cai PL, Hitchman LH, Mohamed AH, et al. Endovenous ablation for venous leg ulcers. Cochrane Database Syst Rev. 2023;7:CD009494. PMID: 37497816. DOI: 10.1002/14651858.CD009494.pub3.
checked
Draft and rewrite: Codex (AI) · Verification: Codex blind grading and adversarial audit · Final adjudication: Claude
Reviewed and approved: Chamgap Editorial Team · Approval date: 2026-08-01 · Corrections: none

Cite this verdict

Early endovenous ablation x faster venous leg-ulcer healing Evidence Grade A card
[Chamgap] Early endovenous ablation x faster venous leg-ulcer healing — Evidence Grade A·80. 2 cited sources checked. Source: https://chamgap.com/en/verdicts/skin-hair/early-endovenous-ablation-venous-leg-ulcer-healing/ · CC BY 4.0

CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.

!

What this document does and does not do

Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.